In a well‑appearing 5‑year‑old with two weeks of intermittent fever and a white‑cell count of 12.6 ×10⁹/L, should I start amoxicillin‑clavulanate (Augmentin) without a referral?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Do Not Start Augmentin Without Further Evaluation

A WBC of 12.6 ×10⁹/L in a 5-year-old with two weeks of intermittent fever is insufficient to justify empiric antibiotics without establishing a specific bacterial diagnosis—you need to determine whether this represents acute bacterial sinusitis, and if so, whether risk factors warrant amoxicillin-clavulanate over plain amoxicillin.

Diagnostic Criteria Must Come First

The WBC count alone does not establish a bacterial infection. According to AAP guidelines, acute bacterial sinusitis requires specific clinical criteria 1, 2:

Three Diagnostic Patterns for Bacterial Sinusitis:

  1. Persistent symptoms (most common): Nasal discharge or daytime cough lasting >10 days without improvement
  2. Worsening symptoms: New or worsening fever, cough, or nasal discharge after initial improvement from a viral URI
  3. Severe symptoms: Fever ≥39°C plus purulent nasal discharge for ≥3 consecutive days

Your patient has "intermittent fever" for two weeks—this does not clearly fit any of these patterns. Intermittent fever is atypical for acute bacterial sinusitis, which typically presents with persistent or worsening symptoms.

The WBC Count Has Limited Utility Here

Research shows that WBC counts can help avoid unnecessary antibiotics in URIs, but a count of 12.6 ×10⁹/L falls in an indeterminate zone 3. The study found that WBC <15,000/mm³ generally supported withholding antibiotics in children without a clear bacterial diagnosis. Your patient's count of 12.6 is below this threshold, actually arguing against empiric antibiotics.

If Bacterial Sinusitis Is Confirmed: Choosing the Right Antibiotic

Start with Plain Amoxicillin Unless Risk Factors Present

Plain amoxicillin (45 mg/kg/day in 2 divided doses) is first-line for uncomplicated bacterial sinusitis 1. Reserve amoxicillin-clavulanate for patients with:

  • Age <2 years
  • Daycare attendance
  • Antibiotic use within past 30 days
  • Moderate-to-severe illness
  • Geographic areas with high β-lactamase-producing H. influenzae (>10%)

If Risk Factors Are Present: High-Dose Amoxicillin-Clavulanate

Use 80-90 mg/kg/day of the amoxicillin component (with 6.4 mg/kg/day clavulanate) in 2 divided doses 1, 4. The most recent large comparative study found no difference in treatment failure between amoxicillin-clavulanate and plain amoxicillin, but significantly more gastrointestinal adverse events and yeast infections with the combination 5.

Critical Pitfalls to Avoid

  1. Do not prescribe antibiotics based solely on WBC count—establish a specific bacterial diagnosis first
  2. Do not use amoxicillin-clavulanate as first-line unless risk factors are present—it increases adverse events without improving outcomes 5
  3. Do not ignore the atypical presentation—intermittent fever for two weeks warrants consideration of non-bacterial causes or referral for further evaluation

What You Should Do Instead

Before prescribing any antibiotic:

  • Clarify the fever pattern: truly intermittent or persistent?
  • Document specific sinusitis symptoms: purulent nasal discharge, daytime cough, facial pain/pressure
  • Assess illness severity and risk factors listed above
  • Consider that two weeks of intermittent fever may warrant investigation beyond simple sinusitis (e.g., occult bacterial focus, atypical infection, non-infectious cause)

If diagnostic criteria for bacterial sinusitis are met AND the child appears well with no risk factors: Start plain amoxicillin 45 mg/kg/day for 10 days 1.

If risk factors are present: Use high-dose amoxicillin-clavulanate 90 mg/kg/day 1, 4.

If the clinical picture remains unclear or the child appears unwell: Referral is appropriate—the atypical presentation and duration warrant further evaluation rather than empiric treatment.

Related Questions

For a patient traveling abroad without access to healthcare or refrigeration, who can take tablets or liquid, which is the preferred regimen—amoxicillin 875 mg twice daily for 10 days or amoxicillin‑clavulanate (Augmentin) 875 mg/125 mg twice daily for 10 days?
What dose in milliliters of Augmentin DS (amoxicillin/clavulanate) 457 mg per 5 ml should be given to a 16‑kg girl?
Does amoxicillin-clavulanate cover bacteria that are susceptible to penicillin?
What is the recommended dosing, administration, and contraindications for amoxicillin/clavulanate (co‑amoxiclav) in adults?
Can Augmentin (amoxicillin + clavulanate potassium) be safely co‑administered with ACE inhibitors without dose adjustment?
Which infections result from suppression of cell-mediated immunity?
Does atenolol cause vivid or unpleasant dreams, and which beta‑blocker is associated with the lowest incidence of bad dreams?
What treatment regimen should be used for a patient with bone‑only metastatic breast cancer that is estrogen‑receptor (ER) and progesterone‑receptor (PR) positive, HER2‑negative, progressing on tamoxifen, when a CDK4/6 inhibitor is not affordable?
What impression statement should be documented for a patient who meets criteria for a major depressive episode of moderate severity, without psychotic features, bipolar spectrum signs, or significant substance use, presenting with persistent low mood, anhedonia, fatigue, difficulty concentrating, and sleep disturbance for more than two weeks causing functional impairment, and who has no prior antidepressant trials or contraindications to first‑line pharmacotherapy?
Which infectious disease is NOT predisposed by the anti‑CD20 monoclonal antibody rituximab (Rituxan)?
In a patient with thrombocytopenia confirmed with citrate anticoagulated sample, should follow‑up platelet counts always be performed using citrate?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.